FREEING PATIENTS FROM THE TYRANNY OF CANCER
Oncology Diagnostic System
TellBio Inc. is a development stage biotechnology company with the goal to revolutionize the detection and treatment of cancer through its unique and proprietary circulating tumor cells (CTCs) technology and complementary therapeutics platform. Archimedic helped Tellbio with the design, development, and manufacturing of diagnostic units currently in research use only.
AN INTEGRATED DESIGN APPROACH
Archimedic led the electromechanical design of the TellDX CTC isolator, including schematic capture, Printed Circuit Board (PCB) layout and fabrication, software integration, mechanical design, and systems integration.
Prototyping & Testing
Archimedic led several iterations of prototyping and testing operations to achieve the desired functionality and usability.
SUPPORTING CLINICAL RESEARCH
Manufacturing & Qualifying
Archimedic led the production of early-stage systems for research use only. This process entailed supply chain development, procurement, subsystem build and test, software integration, and final unit qualification. Archimedic provided low-volume manufacturing services to support Tellbio's needs.
CHIEF EXECUTIVE OFFICER
Pritesh Gandhi, PharmD
“Archimedic has helped the Tellbio team execute on critical business milestones and achieve our goal of manufacturing a high quality system in a timely fashion so as to advance oncology research.”
SVP, HEAD OF OPERATIONS
Annie Partisano, PharmD, MS
“Not only has Archimedic provided the technical expertise we need, but they continuously kept our projects on-time, on-budget, and focused on the right issues.”